Renaissance Technologies (RenTech)'s ARTV Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 151,000 shares of Artiva Biotherapeutics, Inc. (ARTV) worth $1.46 M, representing 0.00% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in ARTV for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 70,962 shares. Largest reduction occurred in Q1 2026, reducing 36,162 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Artiva Biotherapeutics (ARTV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Artiva Biotherapeutics (ARTV) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +70,962 | Add 88.66% | 151,000 | $9.70 |
| Q1 2026 | -36,162 | Reduce 31.12% | 80,038 | $6.44 |
| Q4 2025 | +37,053 | Add 46.82% | 116,200 | $4.29 |
| Q3 2025 | +79,147 | New Buy | 79,147 | $2.87 |
Renaissance Technologies (RenTech)'s Artiva Biotherapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Artiva Biotherapeutics, Inc. (ARTV) in Q3 2025, acquiring 79,147 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Artiva Biotherapeutics, Inc. (ARTV) for 4 quarters since Q3 2025.
Renaissance Technologies (RenTech)'s largest addition to Artiva Biotherapeutics, Inc. (ARTV) was in Q3 2025, adding 79,147 shares worth $227,152.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 151,000 shares of Artiva Biotherapeutics, Inc. (ARTV), valued at approximately $1.46 M.
As of the Q2 2026 filing, Artiva Biotherapeutics, Inc. (ARTV) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Artiva Biotherapeutics, Inc. (ARTV) was 151,000 shares, as reported at the end of Q2 2026.